Marta Amorós-Pérez

Marta Amorós-Pérez

Auto-generated profile, based on publicly available information

Marta Amorós-Pérez

Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid. Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2023 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
SZSeyedeh M. Zekavat
Seyedeh M. Zekavat
VVVanesa Viana-Huete
Vanesa Viana-Huete
NMNuria Matesanz
Nuria Matesanz
SJSaman Doroodgar Jorshery
Saman Doroodgar Jorshery
MZMaría A. Zuriaga
María A. Zuriaga
DKDerek Klarin
Derek Klarin


1 September 2025 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
MAMarta Amorós-Pérez
Marta Amorós-Pérez
AMAlberto Del Monte-Monge
Alberto Del Monte-Monge
PGPilar Gonzalo
Pilar Gonzalo
MAMaría J. Andrés-Manzano
María J. Andrés-Manzano
CLCristina Rius Leiva
Cristina Rius Leiva
VAVicente Andrés
Vicente Andrés
BACKGROUND: Aging is the primary risk factor for atherosclerosis, a degenerative process regulated by immune cells and the leading cause of death worldwide. Previous studies on premature aging syndromes have linked atherosclerosis to defects in A-type lamins, key nuclear envelope components. However, whether these defects influence atherosclerosis during normal aging remains unexplored. Here, we examined how aging affects lamin A/C expression in circulating leukocytes and investigated the impact of manipulating their expression in hematopoietic cells on their function and atherosclerosis progression. METHODS: Flow cytometry assessed lamin A/C expression in human circulating leukocytes. Bone marrow from donor mice was transplanted into lethally irradiated, Ldlr −/− -deficient mice to study leukocyte extravasation into the vessel wall via intravital microscopy in the cremaster muscle, and high-fat-diet–induced atherosclerosis via Oil Red O staining of the aorta and carotid arteries. Single-cell RNA sequencing of the aorta was conducted to identify transcriptional changes associated with hematopoietic cell lamin A/C gain-of-function or loss-of-function. RESULTS: Human aging is associated with lower levels of lamin A/C expression in blood-borne leukocytes. To evaluate the functional relationship between hematopoietic lamin A/C expression and atherosclerosis development, we used Lmna -null mice and Lmna tg mice, the latter being the first in vivo model of lamin A gain-of-function. Transplanting lamin A/C–deficient bone marrow into Ldlr −/− mice increased leukocyte extravasation into the vessel wall and accelerated atherosclerosis. Conversely, transplantation of bone marrow overexpressing lamin A into Ldlr −/− receptor mice reduced leukocyte extravasation and atherosclerosis. Single-cell RNA sequencing of atherosclerotic mouse aorta revealed that alterations to hematopoietic cell lamin A/C expression primarily modify the transcriptome of immune cell populations and endothelial cells, affecting their functionality. CONCLUSIONS: We suggest that the age-related decline in lamin A/C expression in blood-borne immune cells contributes to increased leukocyte extravasation and atherosclerosis, highlighting lamin A/C as a novel regulator of age-related atherosclerosis.

8 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RBRaquel Gomez Bris
Raquel Gomez Bris
MZMarina Ortega Zapero
Marina Ortega Zapero
BHBeatriz Herrero-Fernández
Beatriz Herrero-Fernández
VFVíctor Fanjul
Víctor Fanjul
NVNicolás de la Madrid de Vega
Nicolás de la Madrid de Vega
Jose M Gonzalez-GranadoJose M Gonzalez-Granado
Jose M Gonzalez-Granado
Inflammatory bowel disease (IBD) arises from dysregulated crosstalk between innate immune, adaptive immune, and stromal compartments, yet the compartment-specific mechanisms driving tissue injury and tumorigenesis remain incompletely defined. To address this gap, we used conditional knockout and overexpression mouse models together with human IBD biopsy analysis to dissect the compartment-specific roles of lamin A/C in intestinal inflammation and colitis-associated tumorigenesis. Pan-hematopoietic lamin A/C deletion attenuated acute dextran sulfate sodium (DSS)-induced colitis. Myeloid-specific lamin A/C deletion ameliorated chronic colitis and was associated with altered dendritic cell (DC) programs, enhanced regulatory T cell (Treg) responses, and reduced effector T cell activation. Adoptive transfer of lamin A/C-deficient bone marrow-derived DCs recapitulated this reduced-damage phenotype in DSS colitis, while proteomic profiling revealed reduced antigen-processing and inflammatory programs together with enhanced metabolic and mucosal defense pathways. T cell-specific lamin A/C deletion reduced the Th1/Treg ratio and limited tumor development by suppressing chronic inflammation, whereas T cell-specific lamin A/C overexpression promoted severe Th1-skewed pathology, sustained intestinal inflammation, and increased colitis-associated tumor burden. Stromal fibroblast-specific lamin A/C deletion generated a tissue-protective niche characterized by enhanced epithelial barrier gene expression, regulatory cytokine production, and remodeling of the local immune milieu. Human IBD biopsies revealed compartment-specific lamin A/C alterations consistent with the murine findings. In lamina propria CD3⁺ T cells, lamin A/C levels were blunted in IBD and associated with local histological severity rather than IBD diagnosis, whereas epithelial lamin A/C showed a steeper crypt-axis spatial gradient in a Crohn’s disease-specific pattern. Together, these findings identify lamin A/C as a cell-type- and context-dependent regulator of intestinal inflammation and tumorigenesis.

1 July 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
MAMarta Amorós-Pérez
Marta Amorós-Pérez
MZMaría A. Zuriaga
María A. Zuriaga
VZVirginia Zorita
Virginia Zorita
BRBeatriz L. Ramos-Neble
Beatriz L. Ramos-Neble
NMNuria Matesanz
Nuria Matesanz
JFJosé Javier Fuster
José Javier Fuster
BACKGROUND: Clonal hematopoiesis driven by somatic mutations is an emerging cardiovascular risk factor, and the DNA damage response gene PPM1D is among the most frequently mutated genes. Mutations in PPM1D are enriched in cancer patients and survivors, where cytotoxic therapies promote the expansion of mutant clones, a condition termed therapy-related clonal hematopoiesis. Although PPM1D -mutant clonal hematopoiesis has been associated with increased risk and poorer prognosis of atherosclerotic cardiovascular disease in humans, it remains unclear whether these mutations, or their expansion under cytotoxic stress, causally contribute to atherosclerosis. METHODS: We modeled PPM1D -mutant clonal hematopoiesis in Ldlr −/− mice through bone marrow transplantation strategies. Conventional transplantation approaches were used to generate mice with complete or partial hematopoietic reconstitution by cells carrying monoallelic or biallelic gain-of-function Ppm1d R451X mutations. To mimic therapy-related clonal hematopoiesis, we used a nonconditioned adoptive transfer model in which a small fraction of mutant hematopoietic cells was introduced into recipients, followed by fractionated low-dose γ-radiation to promote clonal expansion. All mice were fed a Western diet to induce atherosclerosis. Clonal dynamics, plaque size and characteristics, and macrophage functions were evaluated using flow cytometry, histopathology, and in vitro assays. RESULTS: Ppm1d -mutant cells expanded in blood and bone marrow after low-dose radiation, but not in nonirradiated mice. Across all transplantation strategies, Ppm1d mutations did not affect plasma cholesterol, atherosclerotic plaque size, or composition. In vitro, mutant macrophages showed no alterations in proliferation, cytokine expression, or cholesterol handling, although apoptosis in response to genotoxic stress was modestly reduced (≈20%). CONCLUSIONS: Ppm1d -mutant hematopoietic cells expand predominantly under genotoxic stress and do not promote atherosclerosis in mice under the conditions tested. These findings raise the possibility that the association of PPM1D mutations with atherosclerotic cardiovascular disease may, at least in part, reflect exposure to DNA damage response–activating stressors that independently promote clonal expansion and atherosclerosis, rather than direct causality.